journal article·2023

Biomimetic polymeric transcatheter heart valve leaflets with low calcification and good regenerative ability

Xiaoxiao Wang, Honghui Jiang, Wenjie Zhang, Yuanyuan Kong, Deling Kong, Jing Liu, Zhihong Wang

Journal of Materials Chemistry B· Volume 11· Issue 25
Publisher page

Abstract

Transcatheter aortic valve replacement (TAVR) technology is quickly advancing in clinic, however, as it expands to low-risk populations and younger patients (age <65 years), device durability is becoming a major challenge. Tissue-engineered heart valves (TEHVs) are a potential alternative. In this study, a bionic tri-layer tissue-engineered heart valve was constructed using poly (L-lactate-co-ε-caprolactone) (PLCL), gelatin (GEL), hyaluronic acid (HA) and silk fibroin (SF), to simulate the fibrosa, spongiosa and ventricular layer of natural heart valves. To obtain a scaffold with sufficient strength and regenerative capacity, we optimized the ratio of components of each layer. The physical and mechanical properties were tested, and the cytocompatibility, calcification deposition and regeneration potential were tested in a rat model of subcutaneous implantation. Finally, the hydrodynamic function of the new TAVR device was verified. The results demonstrated that the strength of the tri-layer valve could reach up to 10 MPa, significantly higher than that of the PLCL and mono-layer groups. Most importantly, calcification related gene expression was down-regulated in the TEHV groups compared to valvular interstitial cells (VICs) treated with calcification induced medium, and calcification levels of TEHVs in in vivo assay were below 0.5 μg mg-1. Besides, we found HA in the middle layer was very conducive to rapid cell infiltration and good angiogenesis, which ultimately promoted host tissue regeneration at 8 weeks after implantation. Collectively, we provide a bionic tri-layer electrospun leaflet with appropriate mechanical strength, low calcification and good regenerative capacity, which has great potential as a TEHV leaflet.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac Valve Diseases and Treatments · Electrospun Nanofibers in Biomedical Applications · Aortic Disease and Treatment Approaches

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, 236 Baidi Road, Nankai district, Tianjin 300192, China

Tianjin Center for Medical Device Evaluation and Inspection, Tianjin, China

Key Laboratory of Bioactive Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, College of Life Science, Nankai University, Tianjin 300071, China

Tianjin Enterprise Key Laboratory for Application Research of Hyaluronic Acid, Tianjin 300385, China

Funding

National Natural Science Foundation of China · Science Fund for Distinguished Young Scholars of Tianjin · Fundamental Research Funds for the Central Universities

References (36)

Show source-provided references
1. Braghiroli · Cardiovasc. Diagn. Ther. · 2020 · 10 · 5910.21037/cdt.2019.09.12 ↗
2. Sellers · JACC Cardiovasc. Imaging · 2019 · 12 · 13510.1016/j.jcmg.2018.06.028 ↗
3. Sulejmani · J. Mech. Behav. Biomed. Mater. · 2019 · 97 · 15910.1016/j.jmbbm.2019.05.020 ↗
4. Wang · Mater. Sci. Eng., C · 2021 · 121 · 11187210.1016/j.msec.2021.111872 ↗
5. Stasiak · Biomater. Sci. · 2020 · 8 · 446710.1039/D0BM00412J ↗
6. Kereiakes · JACC: Cardiovasc. Interventions · 2021 · 14 · 2754
7. Bui · Adv. Healthcare Mater. · 2021 · 10 · 210011510.1002/adhm.202100115 ↗
8. Eckert · Acta Biomater. · 2013 · 9 · 465310.1016/j.actbio.2012.09.031 ↗
9. Uiterwijk · JACC Basic Transl. Sci. · 2020 · 5 · 118710.1016/j.jacbts.2020.09.011 ↗
10. Masoumi · Biomaterials · 2014 · 35 · 777410.1016/j.biomaterials.2014.04.039 ↗
11. Chen · J. Biomed. Mater. Res., Part B · 2020 · 108 · 72910.1002/jbm.b.34427 ↗
12. Wu · Mater. Sci. Eng., C · 2018 · 82 · 12110.1016/j.msec.2017.08.072 ↗
13. Duan · J. Biomed. Mater. Res., Part A · 2013 · 101 · 125510.1002/jbm.a.34420 ↗
14. Cheng · Adv. Healthcare Mater. · 2022 · 11 · e210205910.1002/adhm.202102059 ↗
15. Shah · Biomaterials · 2008 · 29 · 206010.1016/j.biomaterials.2008.01.001 ↗
16. Liu · J. Mater. Chem. B · 2017 · 5 · 178710.1039/C6TB03147A ↗
17. Bottani · Biomolecules · 2020 · 10 · 58910.3390/biom10040589 ↗
18. Yang · Nanoscale · 2019 · 11 · 1769910.1039/C9NR05730G ↗
19. Liu · ACS Biomater. Sci. Eng. · 2019 · 5 · 145210.1021/acsbiomaterials.8b01311 ↗
20. Pham · Biomacromolecules · 2006 · 7 · 279610.1021/bm060680j ↗
21. Hasan · J. Biomech. · 2014 · 47 · 194910.1016/j.jbiomech.2013.09.023 ↗
22. Caffrey · Otolaryngol.-Head Neck Surg. · 2013 · 148 · 57610.1177/0194599812474228 ↗
23. Jordan · Biomaterials · 2007 · 28 · 119110.1016/j.biomaterials.2006.09.048 ↗
24. Woodhouse · Biomaterials · 2004 · 25 · 454310.1016/j.biomaterials.2003.11.043 ↗
25. Kasimir · Thromb. Haemostasis · 2005 · 94 · 56210.1160/TH05-01-0025 ↗
26. Zhang · Sci. Rep. · 2015 · 5 · 1432610.1038/srep14326 ↗
27. Shin · J. Mater. Chem. B · 2017 · 5 · 31810.1039/C6TB02258H ↗
28. Christopherson · Biomaterials · 2009 · 30 · 55610.1016/j.biomaterials.2008.10.004 ↗
29. Lamplot · Curr. Cancer Ther. Rev. · 2013 · 9 · 55
30. Wagner · Sarcoma · 2011 · 2011 · 325238
31. Zhao · J. Cell. Biochem. · 2005 · 95 · 110.1002/jcb.20411 ↗
32. Risau · Nature · 1997 · 386 · 67110.1038/386671a0 ↗
33. Murali · J. Biomed. Mater. Res., Part A · 2016 · 104 · 38810.1002/jbm.a.35574 ↗
34. Lucas · J. Immunol. · 2010 · 184 · 396410.4049/jimmunol.0903356 ↗
35. Sukubo · Int. J. Surg. · 2015 · 24 · 12410.1016/j.ijsu.2015.07.719 ↗
36. Wu · J. Mater. Chem. B · 2015 · 3 · 576010.1039/C5TB00599J ↗